Care for the patient receiving vesicant chemotherapy


Before vesicant administration, the nurse should:

Peripheral neuropathy

Inform the individual concerning the signs or symptoms, and instruct the individual to report them immediately. Immediate signs or symptoms include pain and burning in the administration site and redness or swelling in the site of the injection. Delayed signs or symptoms include pain, skin discoloration, and alter in skin integrity.

Choose the optimal site for peripheral placement. Don't use an old IV line due to questionable integrity. Avoid sites like the inner wrist, the dorsum of the hand, and also the antecubital fossa because of the underlying tendons and arteries. Use larger veins located between your wrist and also the elbow joint.

Make use of a 20- to 23-gauge along with a 23- to 25-gauge butterfly needle or flexible catheter. Verify for adequate blood return before proceeding using the treatment.

For peripheral lines, make sure the patency of the vein by feeling for any bruit across the venous track having a 10-mL normal saline IV push. Don't pinch the IV tubing to check on patency.

Read the CVAD placement before accessing for that first time. Anchor the needle securely to avoid dislodgement and also to allow direct visualization of the insertion site. Make use of a transparent, occlusive dressing for better visualization of the insertion site. Assess blood return continuously by drawing back after every 1 to 2 mL of the drug is run.

Legal Disclaimer

Our website is not responsible for the information contained by this article. Articleinput.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.

Note: This article was sent to us by: Kyle Jordan at 07262011

Related Articles

1. Mitotic inhibitors and camptothecins in chemotherapy
Mitotic Inhibitors Mitotic inhibitors hinder the development of the mitotic spindle, causing metaphase arrest. They're primarily referred to as M-phase active, ho...

2. What is combination chemotherapy how does it fight cancer
Based on the Gompertzian type of tumor growth, tumors in their initial phases grow rapidly simply because they have a superior growth fraction. Eventually, because the tumo...

3. Monoclonal antibodies and their role in chemotherapy
Many tumor cells express substances on the surface that are unique to tumor cells. These substances might be absent or found in small quantities in normal cells, making tum...

4. Cytokines, interferons and toxicities in chemotherapy
Cytokines Cytokines are naturally sourced substances released from stimulated cells of the immune system. There is a big part in mediating the game of the immune ...

5. Interleukins in chemotherapy and cancer treatment
Interleukins are regulatory substances made by lymphocytes and monocytes. They bind to focus on cells to deliver messages between leukocytes. Interleukins demonstrate an ar...

6. Patient and family education for biotherapy in cancer treatment
Patient and family teaching highly relevant to biotherapy is a vital function of the oncology nurse. Nurses are likely involved in obtaining informed consent before initiat...

7. Preventing chemotherapy errors for maximum patient safety
The chemotherapy administration process provides many opportunities for a number of medical professionals to make mistakes. The mistake may occur anywhere in the chemothera...

8. Routes of administration for chemotherapy in cancer patients
Following pretreatment assessment the RN may administer the chemotherapy. As advances in chemotherapy occur, the routes of administration still evolve. The option of drug r...

9. Minimizing contact with chemotherapeutic agents
Because of the healthcare personnel who handles antineoplastic agents, questions have arisen about possible long-term perils associated with contact with these drugs. The t...